Logo
C

Cisbio

113 employees

Now part of PerkinElmer, Cisbio develops and markets products and technologies used for in vitro diagnostics and drug discovery. With the proprietary technology, HTRF®, the organization is a leader in homogeneous fluorescence detection methods, and offers first-class assays and services for drug discovery researchers. In addition, Cisbio Bioassays provides a broad range of immunoassays for in vitro diagnostics, mainly tailored for cancerous pathologies, as well as metabolic and auto-immune diseases. Based in Codolet, France, Cisbio owns facilities in Bedford, MA, U.S.A., in Chiba, Japan and Shanghai, China, and markets its offering globally.

Basic info

Industry

Biotechnology

Sectors

Biotechnology

Date founded

1985

Funding rounds raised

C

Cisbio raised undisclosed on July 1, 2016

Investors: Tikehau Capital

FAQ